Compugen Ltd. diskutieren
Compugen Ltd.
WKN: 553001 / Symbol: CGEN / Name: Compugen / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
2,02 €
2,05 %
Compugen Ltd. (NASDAQ: CGEN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $4.00 price target on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target raised by analysts at Stifel Nicolaus from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen (CGEN) is now covered by Lake Street Capital. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen (CGEN) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for CGEN provided by MarketBeat
Neueste Beiträge
Mizuho in WAVE Life Sciences Ltd diskutieren